MARKER THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $44.0M | $42.4M |
| FY2022 | — | $19.6M | $11.8M |
| FY2023 | — | $14.1M | $15.1M |
| FY2024 | — | $18.6M | $19.2M |
| FY2025 | — | $16.8M | $16.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $44.0M | $42.4M |
| FY2022 | — | $19.6M | $11.8M |
| FY2023 | — | $14.1M | $15.1M |
| FY2024 | — | $18.6M | $19.2M |
| FY2025 | — | $16.8M | $16.1M |